Anti-obesity drugs are the drugs that help in reducing or controlling body mass, either by decreasing the craving or increasing the consumption of calories. Appetite control is achieved through the use of agonists for appetite suppressing pathways.
Scope of the Report:
This report focuses on the Anti-Obesity Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Geographically, North America captures the largest market share on account of increasing obese population. As per the historical trends, more than one-third of the U.S. population is obese. However, Asia Pacific is anticipated to grow at the fastest rate due to increasing demand for the drugs and awareness about the risk associated with obesity. According to WHO, 13.0% of the population were obese in 2014. In developing countries the rate of childhood obesity is increasing and has been 30.0% higher than that of developed countries.
The worldwide market for Anti-Obesity Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Bristol-Myers Squibb
- Eisai Company
- FlaxoSithKline plc.
- Novo Nordisk
- Alizyme
- BoehringerIngelheim GmbH
- Pfizer
- Takeda Pharmaceutical
- Rhythm Pharmaceuticals
- Shionogi USA
- Vivus
- Zafgen
- Norgine Pharmaceuticals Ltd.
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Centrally Acting Anti-obesity Drugs
- Peripherally Acting Anti-obesity Drugs
Market Segment by Applications, can be divided into
- Hospital Use
- Clinic Use
- Household
- Other
There are 15 Chapters to deeply display the global Anti-Obesity Therapeutics market.
Chapter 1, to describe Anti-Obesity Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Anti-Obesity Therapeutics, with sales, revenue, and price of Anti-Obesity Therapeutics, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Anti-Obesity Therapeutics, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Anti-Obesity Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Anti-Obesity Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Anti-Obesity Therapeutics Market 2018, Forecast to 2023
Table of Contents
1 Market Overview
1.1 Anti-Obesity Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Centrally Acting Anti-obesity Drugs
1.2.2 Peripherally Acting Anti-obesity Drugs
1.3 Market Analysis by Applications
1.3.1 Hospital Use
1.3.2 Clinic Use
1.3.3 Household
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bristol-Myers Squibb
2.1.1 Business Overview
2.1.1.1 Bristol-Myers Squibb Description
2.1.1.2 Bristol-Myers Squibb Headquarter, Main Business and Finance Overview
2.1.2 Bristol-Myers Squibb Anti-Obesity Therapeutics Product Introduction
2.1.2.1 Anti-Obesity Therapeutics Production Bases, Sales Regions and Major Competitors
2.1.2.2 Anti-Obesity Therapeutics Product Information
2.1.3 Bristol-Myers Squibb Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Bristol-Myers Squibb Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Bristol-Myers Squibb Anti-Obesity Therapeutics Market Share in 2017
2.2 Eisai Company
2.2.1 Business Overview
2.2.1.1 Eisai Company Description
2.2.1.2 Eisai Company Headquarter, Main Business and Finance Overview
2.2.2 Eisai Company Anti-Obesity Therapeutics Product Introduction
2.2.2.1 Anti-Obesity Therapeutics Production Bases, Sales Regions and Major Competitors
2.2.2.2 Anti-Obesity Therapeutics Product Information
2.2.3 Eisai Company Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Eisai Company Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Eisai Company Anti-Obesity Therapeutics Market Share in 2017
2.3 FlaxoSithKline plc.
2.3.1 Business Overview
2.3.1.1 FlaxoSithKline plc. Description
2.3.1.2 FlaxoSithKline plc. Headquarter, Main Business and Finance Overview
2.3.2 FlaxoSithKline plc. Anti-Obesity Therapeutics Product Introduction
2.3.2.1 Anti-Obesity Therapeutics Production Bases, Sales Regions and Major Competitors
2.3.2.2 Anti-Obesity Therapeutics Product Information
2.3.3 FlaxoSithKline plc. Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 FlaxoSithKline plc. Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global FlaxoSithKline plc. Anti-Obesity Therapeutics Market Share in 2017
2.4 Novo Nordisk
2.4.1 Business Overview
2.4.1.1 Novo Nordisk Description
2.4.1.2 Novo Nordisk Headquarter, Main Business and Finance Overview
2.4.2 Novo Nordisk Anti-Obesity Therapeutics Product Introduction
2.4.2.1 Anti-Obesity Therapeutics Production Bases, Sales Regions and Major Competitors
2.4.2.2 Anti-Obesity Therapeutics Product Information
2.4.3 Novo Nordisk Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Novo Nordisk Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Novo Nordisk Anti-Obesity Therapeutics Market Share in 2017
2.5 Alizyme
2.5.1 Business Overview
2.5.1.1 Alizyme Description
2.5.1.2 Alizyme Headquarter, Main Business and Finance Overview
2.5.2 Alizyme Anti-Obesity Therapeutics Product Introduction
2.5.2.1 Anti-Obesity Therapeutics Production Bases, Sales Regions and Major Competitors
2.5.2.2 Anti-Obesity Therapeutics Product Information
2.5.3 Alizyme Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Alizyme Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Alizyme Anti-Obesity Therapeutics Market Share in 2017
2.6 BoehringerIngelheim GmbH
2.6.1 Business Overview
2.6.1.1 BoehringerIngelheim GmbH Description
2.6.1.2 BoehringerIngelheim GmbH Headquarter, Main Business and Finance Overview
2.6.2 BoehringerIngelheim GmbH Anti-Obesity Therapeutics Product Introduction
2.6.2.1 Anti-Obesity Therapeutics Production Bases, Sales Regions and Major Competitors
2.6.2.2 Anti-Obesity Therapeutics Product Information
2.6.3 BoehringerIngelheim GmbH Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 BoehringerIngelheim GmbH Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global BoehringerIngelheim GmbH Anti-Obesity Therapeutics Market Share in 2017
2.7 Pfizer
2.7.1 Business Overview
2.7.1.1 Pfizer Description
2.7.1.2 Pfizer Headquarter, Main Business and Finance Overview
2.7.2 Pfizer Anti-Obesity Therapeutics Product Introduction
2.7.2.1 Anti-Obesity Therapeutics Production Bases, Sales Regions and Major Competitors
2.7.2.2 Anti-Obesity Therapeutics Product Information
2.7.3 Pfizer Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Pfizer Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Pfizer Anti-Obesity Therapeutics Market Share in 2017
2.8 Takeda Pharmaceutical
2.8.1 Business Overview
2.8.1.1 Takeda Pharmaceutical Description
2.8.1.2 Takeda Pharmaceutical Headquarter, Main Business and Finance Overview
2.8.2 Takeda Pharmaceutical Anti-Obesity Therapeutics Product Introduction
2.8.2.1 Anti-Obesity Therapeutics Production Bases, Sales Regions and Major Competitors
2.8.2.2 Anti-Obesity Therapeutics Product Information
2.8.3 Takeda Pharmaceutical Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Takeda Pharmaceutical Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Takeda Pharmaceutical Anti-Obesity Therapeutics Market Share in 2017
2.9 Rhythm Pharmaceuticals
2.9.1 Business Overview
2.9.1.1 Rhythm Pharmaceuticals Description
2.9.1.2 Rhythm Pharmaceuticals Headquarter, Main Business and Finance Overview
2.9.2 Rhythm Pharmaceuticals Anti-Obesity Therapeutics Product Introduction
2.9.2.1 Anti-Obesity Therapeutics Production Bases, Sales Regions and Major Competitors
2.9.2.2 Anti-Obesity Therapeutics Product Information
2.9.3 Rhythm Pharmaceuticals Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Rhythm Pharmaceuticals Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Rhythm Pharmaceuticals Anti-Obesity Therapeutics Market Share in 2017
2.10 Shionogi USA
2.10.1 Business Overview
2.10.1.1 Shionogi USA Description
2.10.1.2 Shionogi USA Headquarter, Main Business and Finance Overview
2.10.2 Shionogi USA Anti-Obesity Therapeutics Product Introduction
2.10.2.1 Anti-Obesity Therapeutics Production Bases, Sales Regions and Major Competitors
2.10.2.2 Anti-Obesity Therapeutics Product Information
2.10.3 Shionogi USA Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Shionogi USA Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Shionogi USA Anti-Obesity Therapeutics Market Share in 2017
2.11 Vivus
2.11.1 Business Overview
2.11.2 Vivus Anti-Obesity Therapeutics Product Introduction
2.11.3 Vivus Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Zafgen
2.12.1 Business Overview
2.12.2 Zafgen Anti-Obesity Therapeutics Product Introduction
2.12.3 Zafgen Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Norgine Pharmaceuticals Ltd.
2.13.1 Business Overview
2.13.2 Norgine Pharmaceuticals Ltd. Anti-Obesity Therapeutics Product Introduction
2.13.3 Norgine Pharmaceuticals Ltd. Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Anti-Obesity Therapeutics Market Competition, by Manufacturer
3.1 Global Anti-Obesity Therapeutics Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Anti-Obesity Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Anti-Obesity Therapeutics Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Anti-Obesity Therapeutics Manufacturer Market Share in 2017
3.4.2 Top 5 Anti-Obesity Therapeutics Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Anti-Obesity Therapeutics Market Analysis by Regions
4.1 Global Anti-Obesity Therapeutics Sales, Revenue and Market Share by Regions
4.1.1 Global Anti-Obesity Therapeutics Sales by Regions (2013-2018)
4.1.2 Global Anti-Obesity Therapeutics Revenue by Regions (2013-2018)
4.2 North America Anti-Obesity Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Anti-Obesity Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Anti-Obesity Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Anti-Obesity Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Anti-Obesity Therapeutics Sales, Revenue and Growth Rate (2013-2018)
5 North America Anti-Obesity Therapeutics by Countries, Type, Application and Manufacturers
5.1 North America Anti-Obesity Therapeutics Sales, Revenue and Market Share by Countries
5.1.1 North America Anti-Obesity Therapeutics Sales by Countries (2013-2018)
5.1.2 North America Anti-Obesity Therapeutics Revenue by Countries (2013-2018)
5.1.3 United States Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
5.1.4 Canada Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
5.1.5 Mexico Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
5.2 North America Anti-Obesity Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Anti-Obesity Therapeutics Sales by Manufacturers (2016-2017)
5.2.2 North America Anti-Obesity Therapeutics Revenue by Manufacturers (2016-2017)
5.3 North America Anti-Obesity Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Anti-Obesity Therapeutics Sales and Sales Share by Type (2013-2018)
5.3.2 North America Anti-Obesity Therapeutics Revenue and Revenue Share by Type (2013-2018)
5.4 North America Anti-Obesity Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Anti-Obesity Therapeutics Sales and Sales Share by Application (2013-2018)
5.4.2 North America Anti-Obesity Therapeutics Revenue and Revenue Share by Application (2013-2018)
6 Europe Anti-Obesity Therapeutics by Countries, Type, Application and Manufacturers
6.1 Europe Anti-Obesity Therapeutics Sales, Revenue and Market Share by Countries
6.1.1 Europe Anti-Obesity Therapeutics Sales by Countries (2013-2018)
6.1.2 Europe Anti-Obesity Therapeutics Revenue by Countries (2013-2018)
6.1.3 Germany Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
6.1.4 UK Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
6.1.5 France Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
6.1.6 Russia Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
6.1.7 Italy Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
6.2 Europe Anti-Obesity Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Anti-Obesity Therapeutics Sales by Manufacturers (2016-2017)
6.2.2 Europe Anti-Obesity Therapeutics Revenue by Manufacturers (2016-2017)
6.3 Europe Anti-Obesity Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Anti-Obesity Therapeutics Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Anti-Obesity Therapeutics Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Anti-Obesity Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Anti-Obesity Therapeutics Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Anti-Obesity Therapeutics Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Anti-Obesity Therapeutics by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Anti-Obesity Therapeutics Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Anti-Obesity Therapeutics Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Anti-Obesity Therapeutics Revenue by Countries (2013-2018)
7.1.3 China Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
7.1.4 Japan Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
7.1.5 Korea Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
7.1.6 India Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Anti-Obesity Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Anti-Obesity Therapeutics Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Anti-Obesity Therapeutics Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Anti-Obesity Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Anti-Obesity Therapeutics Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Anti-Obesity Therapeutics Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Anti-Obesity Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Anti-Obesity Therapeutics Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Anti-Obesity Therapeutics Revenue and Revenue Share by Application (2013-2018)
8 South America Anti-Obesity Therapeutics by Countries, Type, Application and Manufacturers
8.1 South America Anti-Obesity Therapeutics Sales, Revenue and Market Share by Countries
8.1.1 South America Anti-Obesity Therapeutics Sales by Countries (2013-2018)
8.1.2 South America Anti-Obesity Therapeutics Revenue by Countries (2013-2018)
8.1.3 Brazil Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
8.1.4 Argentina Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
8.1.5 Colombia Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
8.2 South America Anti-Obesity Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Anti-Obesity Therapeutics Sales by Manufacturers (2016-2017)
8.2.2 South America Anti-Obesity Therapeutics Revenue by Manufacturers (2016-2017)
8.3 South America Anti-Obesity Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Anti-Obesity Therapeutics Sales and Sales Share by Type (2013-2018)
8.3.2 South America Anti-Obesity Therapeutics Revenue and Revenue Share by Type (2013-2018)
8.4 South America Anti-Obesity Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Anti-Obesity Therapeutics Sales and Sales Share by Application (2013-2018)
8.4.2 South America Anti-Obesity Therapeutics Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Anti-Obesity Therapeutics by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Anti-Obesity Therapeutics Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Anti-Obesity Therapeutics Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Anti-Obesity Therapeutics Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
9.1.4 UAE Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
9.1.5 Egypt Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
9.1.7 South Africa Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Anti-Obesity Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Anti-Obesity Therapeutics Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Anti-Obesity Therapeutics Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Anti-Obesity Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Anti-Obesity Therapeutics Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Anti-Obesity Therapeutics Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Anti-Obesity Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Anti-Obesity Therapeutics Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Anti-Obesity Therapeutics Revenue and Revenue Share by Application (2013-2018)
10 Global Anti-Obesity Therapeutics Market Segment by Type
10.1 Global Anti-Obesity Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Anti-Obesity Therapeutics Sales and Market Share by Type (2013-2018)
10.1.2 Global Anti-Obesity Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Centrally Acting Anti-obesity Drugs Sales Growth and Price
10.2.1 Global Centrally Acting Anti-obesity Drugs Sales Growth (2013-2018)
10.2.2 Global Centrally Acting Anti-obesity Drugs Price (2013-2018)
10.3 Peripherally Acting Anti-obesity Drugs Sales Growth and Price
10.3.1 Global Peripherally Acting Anti-obesity Drugs Sales Growth (2013-2018)
10.3.2 Global Peripherally Acting Anti-obesity Drugs Price (2013-2018)
11 Global Anti-Obesity Therapeutics Market Segment by Application
11.1 Global Anti-Obesity Therapeutics Sales Market Share by Application (2013-2018)
11.2 Hospital Use Sales Growth (2013-2018)
11.3 Clinic Use Sales Growth (2013-2018)
11.4 Household Sales Growth (2013-2018)
11.5 Other Sales Growth (2013-2018)
12 Anti-Obesity Therapeutics Market Forecast (2018-2023)
12.1 Global Anti-Obesity Therapeutics Sales, Revenue and Growth Rate (2018-2023)
12.2 Anti-Obesity Therapeutics Market Forecast by Regions (2018-2023)
12.2.1 North America Anti-Obesity Therapeutics Market Forecast (2018-2023)
12.2.2 Europe Anti-Obesity Therapeutics Market Forecast (2018-2023)
12.2.3 Asia-Pacific Anti-Obesity Therapeutics Market Forecast (2018-2023)
12.2.4 South America Anti-Obesity Therapeutics Market Forecast (2018-2023)
12.2.5 Middle East and Africa Anti-Obesity Therapeutics Market Forecast (2018-2023)
12.3 Anti-Obesity Therapeutics Market Forecast by Type (2018-2023)
12.3.1 Global Anti-Obesity Therapeutics Sales Forecast by Type (2018-2023)
12.3.2 Global Anti-Obesity Therapeutics Market Share Forecast by Type (2018-2023)
12.4 Anti-Obesity Therapeutics Market Forecast by Application (2018-2023)
12.4.1 Global Anti-Obesity Therapeutics Sales Forecast by Application (2018-2023)
12.4.2 Global Anti-Obesity Therapeutics Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Anti-Obesity Therapeutics Picture
Table Product Specifications of Anti-Obesity Therapeutics
Figure Global Anti-Obesity Therapeutics CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Anti-Obesity Therapeutics CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Anti-Obesity Therapeutics by Types in 2017
Figure Centrally Acting Anti-obesity Drugs Picture
Table Major Manufacturers of Centrally Acting Anti-obesity Drugs
Figure Peripherally Acting Anti-obesity Drugs Picture
Table Major Manufacturers of Peripherally Acting Anti-obesity Drugs
Figure Anti-Obesity Therapeutics Sales Market Share by Applications in 2017
Figure Hospital Use Picture
Figure Clinic Use Picture
Figure Household Picture
Figure Other Picture
Figure United States Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure France Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure UK Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure China Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure India Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Table Bristol-Myers Squibb Headquarter, Established, Main Business and Finance Overview (2017)
Table Bristol-Myers Squibb Anti-Obesity Therapeutics Production Bases, Sales Regions and Major Competitors
Table Bristol-Myers Squibb Anti-Obesity Therapeutics Product
Table Bristol-Myers Squibb Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Bristol-Myers Squibb Anti-Obesity Therapeutics Sales Market Share in 2017
Figure Global Bristol-Myers Squibb Anti-Obesity Therapeutics Revenue Market Share in 2017
Table Eisai Company Headquarter, Established, Main Business and Finance Overview (2017)
Table Eisai Company Anti-Obesity Therapeutics Production Bases, Sales Regions and Major Competitors
Table Eisai Company Anti-Obesity Therapeutics Product
Table Eisai Company Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Eisai Company Anti-Obesity Therapeutics Sales Market Share in 2017
Figure Global Eisai Company Anti-Obesity Therapeutics Revenue Market Share in 2017
Table FlaxoSithKline plc. Headquarter, Established, Main Business and Finance Overview (2017)
Table FlaxoSithKline plc. Anti-Obesity Therapeutics Production Bases, Sales Regions and Major Competitors
Table FlaxoSithKline plc. Anti-Obesity Therapeutics Product
Table FlaxoSithKline plc. Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global FlaxoSithKline plc. Anti-Obesity Therapeutics Sales Market Share in 2017
Figure Global FlaxoSithKline plc. Anti-Obesity Therapeutics Revenue Market Share in 2017
Table Novo Nordisk Headquarter, Established, Main Business and Finance Overview (2017)
Table Novo Nordisk Anti-Obesity Therapeutics Production Bases, Sales Regions and Major Competitors
Table Novo Nordisk Anti-Obesity Therapeutics Product
Table Novo Nordisk Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Novo Nordisk Anti-Obesity Therapeutics Sales Market Share in 2017
Figure Global Novo Nordisk Anti-Obesity Therapeutics Revenue Market Share in 2017
Table Alizyme Headquarter, Established, Main Business and Finance Overview (2017)
Table Alizyme Anti-Obesity Therapeutics Production Bases, Sales Regions and Major Competitors
Table Alizyme Anti-Obesity Therapeutics Product
Table Alizyme Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Alizyme Anti-Obesity Therapeutics Sales Market Share in 2017
Figure Global Alizyme Anti-Obesity Therapeutics Revenue Market Share in 2017
Table BoehringerIngelheim GmbH Headquarter, Established, Main Business and Finance Overview (2017)
Table BoehringerIngelheim GmbH Anti-Obesity Therapeutics Production Bases, Sales Regions and Major Competitors
Table BoehringerIngelheim GmbH Anti-Obesity Therapeutics Product
Table BoehringerIngelheim GmbH Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global BoehringerIngelheim GmbH Anti-Obesity Therapeutics Sales Market Share in 2017
Figure Global BoehringerIngelheim GmbH Anti-Obesity Therapeutics Revenue Market Share in 2017
Table Pfizer Headquarter, Established, Main Business and Finance Overview (2017)
Table Pfizer Anti-Obesity Therapeutics Production Bases, Sales Regions and Major Competitors
Table Pfizer Anti-Obesity Therapeutics Product
Table Pfizer Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Pfizer Anti-Obesity Therapeutics Sales Market Share in 2017
Figure Global Pfizer Anti-Obesity Therapeutics Revenue Market Share in 2017
Table Takeda Pharmaceutical Headquarter, Established, Main Business and Finance Overview (2017)
Table Takeda Pharmaceutical Anti-Obesity Therapeutics Production Bases, Sales Regions and Major Competitors
Table Takeda Pharmaceutical Anti-Obesity Therapeutics Product
Table Takeda Pharmaceutical Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Takeda Pharmaceutical Anti-Obesity Therapeutics Sales Market Share in 2017
Figure Global Takeda Pharmaceutical Anti-Obesity Therapeutics Revenue Market Share in 2017
Table Rhythm Pharmaceuticals Headquarter, Established, Main Business and Finance Overview (2017)
Table Rhythm Pharmaceuticals Anti-Obesity Therapeutics Production Bases, Sales Regions and Major Competitors
Table Rhythm Pharmaceuticals Anti-Obesity Therapeutics Product
Table Rhythm Pharmaceuticals Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Rhythm Pharmaceuticals Anti-Obesity Therapeutics Sales Market Share in 2017
Figure Global Rhythm Pharmaceuticals Anti-Obesity Therapeutics Revenue Market Share in 2017
Table Shionogi USA Headquarter, Established, Main Business and Finance Overview (2017)
Table Shionogi USA Anti-Obesity Therapeutics Production Bases, Sales Regions and Major Competitors
Table Shionogi USA Anti-Obesity Therapeutics Product
Table Shionogi USA Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Shionogi USA Anti-Obesity Therapeutics Sales Market Share in 2017
Figure Global Shionogi USA Anti-Obesity Therapeutics Revenue Market Share in 2017
Table Vivus
Table Vivus Anti-Obesity Therapeutics
Table Zafgen
Table Zafgen Anti-Obesity Therapeutics
Table Norgine Pharmaceuticals Ltd.
Table Norgine Pharmaceuticals Ltd. Anti-Obesity Therapeutics
Table Global Anti-Obesity Therapeutics Sales by Manufacturer (2016-2017)
Figure Global Anti-Obesity Therapeutics Sales Market Share by Manufacturer in 2016
Figure Global Anti-Obesity Therapeutics Sales Market Share by Manufacturer in 2017
Table Global Anti-Obesity Therapeutics Revenue by Manufacturer (2016-2017)
Figure Global Anti-Obesity Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Global Anti-Obesity Therapeutics Revenue Market Share by Manufacturer in 2017
Table Global Anti-Obesity Therapeutics Price by Manufacturer (2016-2017)
Figure Top 3 Anti-Obesity Therapeutics Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Anti-Obesity Therapeutics Manufacturer (Revenue) Market Share in 2017
Figure Global Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
Figure Global Anti-Obesity Therapeutics Revenue and Growth Rate (2013-2018)
Table Global Anti-Obesity Therapeutics Sales by Regions (2013-2018)
Table Global Anti-Obesity Therapeutics Sales Market Share by Regions (2013-2018)
Table Global Anti-Obesity Therapeutics Revenue by Regions (2013-2018)
Figure Global Anti-Obesity Therapeutics Revenue Market Share by Regions in 2013
Figure Global Anti-Obesity Therapeutics Revenue Market Share by Regions in 2017
Figure North America Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
Figure North America Anti-Obesity Therapeutics Revenue and Growth Rate (2013-2018)
Figure Europe Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
Figure Europe Anti-Obesity Therapeutics Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Anti-Obesity Therapeutics Revenue and Growth Rate (2013-2018)
Figure South America Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
Figure South America Anti-Obesity Therapeutics Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Anti-Obesity Therapeutics Revenue and Growth Rate (2013-2018)
Figure
Global Antioxidant Vitamins Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 100
The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
Global Clavulanate Potassium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030.
North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
Global Amoxicillin Sodium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 84
The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030.
North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
Global Melatonin Supplements Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 93
The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
Global Sleeping Pills Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Zinc Oral Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
Global Zinc Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
Global Anti-Infectives Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
